{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:47:25Z","timestamp":1793933245801,"version":"4.8.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["2025GXNSFAA069989"],"award-info":[{"award-number":["2025GXNSFAA069989"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460677"],"award-info":[{"award-number":["82460677"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204208"],"award-info":[{"award-number":["82204208"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jinorgbio.2025.113206","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T07:17:37Z","timestamp":1766992657000},"page":"113206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Developing a novel binuclear copper complex for enhanced cellular copper uptake and cancer treatment"],"prefix":"10.1016","volume":"277","author":[{"given":"Haoran","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juzheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2025.113206_bb0005","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.3390\/molecules27196485","article-title":"Metallo-drugs in cancer therapy: past, present and future","volume":"27","author":"Lucaciu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0010","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1021\/acsabm.9b01156","article-title":"Aliphatic group-tethered iridium complex as a theranostic agent against malignant melanoma metastasis","volume":"3","author":"Wu","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0015","doi-asserted-by":"crossref","first-page":"13091","DOI":"10.1002\/anie.201807305","article-title":"Selective inhibition of lysine-specific demethylase 5A (KDM5A) using a rhodium(III) complex for triple-negative breast cancer therapy","volume":"57","author":"Yang","year":"2018","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0020","doi-asserted-by":"crossref","first-page":"14587","DOI":"10.1021\/acs.jmedchem.1c01068","article-title":"Developing a novel indium(III) agent based on liposomes to overcome cisplatin-induced resistance in breast cancer by multitargeting the tumor microenvironment components","volume":"64","author":"Jiang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0025","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/acs.jmedchem.8b01031","article-title":"New water-soluble copper(II) complexes with morpholine-thiosemicarbazone hybrids: insights into the anticancer and antibacterial mode of action","volume":"62","author":"Ohui","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0030","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1038\/s41467-021-24845-8","article-title":"Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1","volume":"12","author":"Pan","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0035","doi-asserted-by":"crossref","first-page":"20156","DOI":"10.1021\/acs.jmedchem.4c01467","article-title":"Ruthenium(ii)-arene complex triggers immunogenic ferroptosis for reversing drug resistance","volume":"67","author":"Lv","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0040","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0045","doi-asserted-by":"crossref","unstructured":"N.P. Farrell, Multi-platinum anti-cancer agents. Substitution-inert compounds for tumor selectivity and new targets, Chem. Soc. Rev. 44(2015) 8773\u201385.","DOI":"10.1039\/C5CS00201J"},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0050","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1039\/D1CS00933H","article-title":"Recent development of gold(I) and gold(III) complexes as therapeutic agents for cancer diseases","volume":"51","author":"Lu","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0055","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1021\/acs.chemrev.2c00649","article-title":"Next generation gold drugs and probes: chemistry and biomedical applications","volume":"123","author":"Mertens","year":"2023","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0060","doi-asserted-by":"crossref","first-page":"7803","DOI":"10.1021\/jacs.0c00221","article-title":"A photocaged, water-oxidizing, and nucleolus-targeted Pt(IV) complex with a distinct anticancer mechanism","volume":"142","author":"Deng","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114859","article-title":"New NNN pincer copper complexes as potential anti-prostate cancer agents","volume":"244","author":"Qu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0070","doi-asserted-by":"crossref","first-page":"9594","DOI":"10.1021\/acs.jmedchem.5c00374","article-title":"Advantages of novel anti-cancer selenosemicarbazones: Preferential reactivity of their Fe^III, Cu^II, and Zn^II complexes with key physiological reductants\/Ligands versus isosteric thiosemicarbazones","volume":"68","author":"Dharmasivam","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0075","doi-asserted-by":"crossref","first-page":"9091","DOI":"10.1021\/acs.jmedchem.4c00257","article-title":"Thiosemicarbazone mixed-valence cu(I\/II) complex against lung adenocarcinoma cells through multiple pathways involving cuproptosis","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0080","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.1021\/acs.jmedchem.3c02018","article-title":"Antitumor activity and mechanistic insights of a mitochondria-targeting Cu(I) complex","volume":"67","author":"Xu","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0085","doi-asserted-by":"crossref","first-page":"15676","DOI":"10.1021\/acs.jmedchem.4c01298","article-title":"Pyrazolone-based Zn(II) complexes display antitumor effects in mutant p53-carrying cancer cells","volume":"67","author":"Xhafa","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0090","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1021\/acs.jmedchem.6b00917","article-title":"Anticancer and antiangiogenic iron(II) complexes that target thioredoxin reductase to trigger cancer cell apoptosis","volume":"60","author":"Xie","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0095","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1126\/science.aaz8899","article-title":"Elesclomol alleviates menkes pathology and mortality by escorting cu to cuproenzymes in mice","volume":"368","author":"Guthrie","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0100","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0105","doi-asserted-by":"crossref","first-page":"13509","DOI":"10.1021\/acsami.3c17792","article-title":"Elesclomol-copper nanoparticles overcome multidrug resistance in cancer cells","volume":"16","author":"Wang","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s13046-022-02485-0","article-title":"Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy","volume":"41","author":"Zheng","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202370152","article-title":"Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with \u03b1PD-L1 for enhanced cancer immunotherapy","volume":"35","author":"Guo","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0120","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1186\/s12967-023-04533-5","article-title":"Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications","volume":"21","author":"Tarin","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0125","article-title":"Elesclomol loaded copper oxide nanoplatform triggers cuproptosis to enhance antitumor immunotherapy","volume":"11","author":"Lu","year":"2024","journal-title":"Adv Sci."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0130","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1200\/JCO.2012.44.5585","article-title":"Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma","volume":"31","author":"O'Day","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0135","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1021\/acs.inorgchem.2c04392","article-title":"Dual role of glutathione as a reducing agent and cu-ligand governs the ROS production by anticancer cu-thiosemicarbazone complexes","volume":"62","author":"Ritacca","year":"2023","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0140","doi-asserted-by":"crossref","first-page":"17074","DOI":"10.1039\/D3RA00446E","article-title":"Design, synthesis, and biological evaluation with molecular dynamics study of novel pyrazolo[3,4-d]pyrimidine derivatives as anti-cancer agents","volume":"13","author":"Shaban","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113244","article-title":"Structure-based design of highly selective 2,4,5-trisubstituted pyrimidine CDK9 inhibitors as anti-cancer agents","volume":"214","author":"Shao","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0150","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2174\/1871520620666200721104431","article-title":"Fused and substituted pyrimidine derivatives as profound anti-cancer agents","volume":"21","author":"Abbas","year":"2021","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0155","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2174\/1568026622666220111143949","article-title":"Pyrimidine-fused dinitrogenous penta-heterocycles as a privileged scaffold for anti-cancer drug discovery","volume":"22","author":"Li","year":"2022","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113573","article-title":"Design, synthesis, and biological evaluation of 2,4-diamino pyrimidine derivatives as potent FAK inhibitors with anti-cancer and anti-angiogenesis activities","volume":"222","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-59745-157-4_4","article-title":"LC3 and autophagy","volume":"445","author":"Tanida","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0170","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/EBC20170035","article-title":"Regulation of selective autophagy: the p62\/SQSTM1 paradigm","volume":"61","author":"Lamark","year":"2017","journal-title":"Essays Biochem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0175","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/jcp.25349","article-title":"Mitochondria and mitochondrial ROS in cancer: novel targets for anticancer therapy","volume":"231","author":"Yang","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0180","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cmet.2015.06.006","article-title":"Redox homeostasis and mitochondrial dynamics","volume":"22","author":"Willems","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0185","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41580-022-00523-5","article-title":"Mitochondrial ROS drive cell cycle progression","volume":"23","author":"Heinke","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0190","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1039\/D3DT00317E","article-title":"A cu(I)-based Fenton-like agent inducing mitochondrial damage for photo-assisted enhanced chemodynamic therapy","volume":"52","author":"Hong","year":"2023","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0195","doi-asserted-by":"crossref","first-page":"9823","DOI":"10.1021\/acs.jmedchem.3c00617","article-title":"Exploring the anticancer activity of tamoxifen-based metal complexes targeting mitochondria","volume":"66","author":"Scalcon","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0200","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1021\/acs.jmedchem.2c01798","article-title":"Tumor-targeting NHC-au(I) complex induces immunogenic cell death in hepatocellular carcinoma","volume":"66","author":"Yang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.171","article-title":"JC-1: alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry","volume":"3","author":"Perelman","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0210","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.apsb.2021.11.002","article-title":"Inhibiting DNA methylation alleviates cisplatin-induced hearing loss by decreasing oxidative stress-induced mitochondria-dependent apoptosis via the LRP1-PI3K\/AKT pathway","volume":"12","author":"He","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0215","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41419-023-06154-8","article-title":"Autophagy: regulator of cell death","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0220","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0225","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","article-title":"Biological functions of autophagy genes: a disease perspective","volume":"176","author":"Levine","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0230","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1080\/15548627.2022.2111635","article-title":"TMEM164 is a new determinant of autophagy-dependent ferroptosis","volume":"19","author":"Liu","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114420","article-title":"Design, synthesis and antitumour activity of novel 5(6)-amino-benzimidazolequinones containing a fused morpholine","volume":"238","author":"Wang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0240","doi-asserted-by":"crossref","first-page":"16843","DOI":"10.1021\/acs.jmedchem.3c01551","article-title":"Pioneering 4,11-Dioxo-4,11-dihydro-1H-anthra[2,3-d]imidazol-3-ium compounds as promising survivin inhibitors by targeting ILF3\/NF110 for cancer therapy","volume":"66","author":"Yuan","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0245","doi-asserted-by":"crossref","first-page":"16235","DOI":"10.1021\/acs.jmedchem.4c01065","article-title":"Photoinduction of ferroptosis and cGAS-STING activation by a H2S-responsive iridium(III) complex for cancer-specific therapy","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0250","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nprot.2006.5","article-title":"The comet assay: a method to measure DNA damage in individual cells","volume":"1","author":"Olive","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0255","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1021\/acs.jmedchem.2c01895","article-title":"Development of clioquinol platinum(IV) conjugates as autophagy-targeted antimetastatic agents","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0260","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1021\/acs.jmedchem.4c02445","article-title":"Discovery of highly potent and orally bioavailable histone deacetylase 3 inhibitors as immunomodulators and enhancers of DNA-damage response in cancer therapy","volume":"68","author":"Li","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0265","doi-asserted-by":"crossref","first-page":"17920","DOI":"10.1021\/acs.jmedchem.1c01236","article-title":"Ketoprofen and loxoprofen platinum(IV) complexes displaying antimetastatic activities by inducing DNA damage, inflammation suppression, and enhanced immune response","volume":"64","author":"Li","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0270","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0275","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/sj.cdd.4400938","article-title":"DNA damage and apoptosis","volume":"8","author":"Wang","year":"2001","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jinorgbio.2025.113206_bb0280","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41580-019-0110-x","article-title":"The multiple mechanisms that regulate p53 activity and cell fate","volume":"20","author":"Hafner","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013425003873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013425003873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T08:32:01Z","timestamp":1782117121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013425003873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":56,"alternative-id":["S0162013425003873"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2025.113206","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing a novel binuclear copper complex for enhanced cellular copper uptake and cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2025.113206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113206"}}